Global High Throughput Screening (HTS) Market by Application (Organ-based Screening, Drug Discovery, Cell-, Biochemical Screening) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

In 2016, the global market for high-throughput screening (HTS), was worth USD 15.62 billion. The market is expected to grow at 7.89% during the forecast period. Market growth is being driven by key trends like the increasing number of drug targets that are being screened, which are then used to develop and discover drugs, and the growing investments made by governments and research institutes.

High throughput screening (also known as high content screening) is used primarily for various chemical, genetic, and pharmacological tests. These tests aid in the drug discovery process, from drug design to drug trials and other drug interaction. This involves various liquid handling devices, control software, and other detectors. These help identify active compounds and genetic interactions.

However, these techniques require expertise and software that can store and manage multiple data sets at a rapid rate. This could hinder growth prospects.

Technology Insights

Technological advancements are being supported by a growing demand for better treatments for many conditions. The most crucial step in obtaining the desired results is the analysis of the data processed. Recent trends indicate the use of software and chemical libraries to establish the highest standards for reporting results.

To ensure integrity and accuracy of information and data stored, regulatory bodies are being encouraged to set stricter quality control standards. The market's growth will be affected by the inability to find efficient software to manage automated robotic arms and liquid handling system.

In 2016, cell-based assays accounted for more than 55.0% overall revenue. The most popular cell-based assays were fluorometric imaging plates reader assays. They are visible and can be tested with very small volumes. Ultra high throughput screening, the most recent technology, allows for greater output in a shorter time.

Most companies are currently in transition from 2D-cell cultures to 3D-cell cultures. 3D cells have more lifelike properties and can be tested in the natural environment, which is crucial for drug design and discovery.

There are several steps that could be taken to increase the number of chemical libraries to identify chemical identity hits during testing. The development of hardware or software that can handle and fully automate testing is also possible. In addition to increased funding from governments and other research institutions to adopt new technologies and faster data processing software, there will also be an increase in government funding.

Application Insights

The expansion of the market will be ensured by stiff competition among companies in order to get to the market first. HTS technology has the greatest advantage in that it takes less time to develop a drug. In 2016, the market was dominated by drug discovery programs in terms of revenue. This segment grew in 2016 due to the fact that many of the large and small pharmaceutical companies focus on developing and manufacturing novel molecules for various life-threatening conditions.

These have led to automated high-throughput screening systems and ultra-high-throughput screening techniques being adopted to screen large chemical libraries in order to meet the growing demand for drug target molecules. An automated HTS system, for example, can screen between 10,000 and 100,000 target compounds per hour. uHTS can screen more than 100,000 targets compounds per hour.

Regional Insights

Because of technological advances in the US, North America will likely be the leading market for high-throughput screening during the forecast period. Companies looking to launch a new drug molecule have begun to adopt 3D-cell culture techniques for drug discovery.

Asia Pacific, on the other hand, saw the highest CAGR in the forecast years. This is due to increased efforts to develop new pharmaceutical molecules and new technologies that improve the quality of medicine being supplied. High growth rates are expected in Asia Pacific, with India, China, and Japan.

Market Share Insights from High Throughput Screening (HTS).

The key players in this space include Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc., Tecan Group Ltd., Merck Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.

Companies are being forced to develop faster and more efficient technologies to reduce the time it takes to commercialize new molecules due to fierce competition from manufacturers. This could be a driver for the market's growth during the forecast period.

High Throughput Screening Market Report Scope

The Report Covers Certain Segments

This report forecasts revenue growth at the global, regional, and country levels. It also provides analysis of industry trends in each sub-segment from 2014 through 2025. Grand View Research segmented this report on the global HTS market based upon application, technology, region.

• Technology Outlook (Revenue USD Billion, 2014-2025)

  • Cell-based Assays

    • Fluorometric Imaging Plate Reader Assays

      • Clinical applications (Cardiotoxicity Assays)

      • In-vitro studies (Pharmacophores identification in drug discovery)

    • Reporter-based Assays

      • Clinical applications (Reporter assay for biological system analysis)

      • In-vitro Studies (Genetic reporter assays for cloning tools to live-cell work).

  • 3D Cell Cultures

    • Clinical applications (Regenerative medicine).

    • In-vitro studies (Drug discovery, Molecular cell biology)

  • Ultra High Throughput Screening

• Application Outlook (Revenue, USD Billion, 2014 - 2025)

  • Programs for drug discovery

  • Programs in chemical biology

  • Biochemical screening

  • Screening cell- and organ-based

• Regional Outlook (Revenue USD Billion, 2014-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • India

  • Latin America

    • Brazil

  • MEA

    • South Africa

These are the most frequently asked questions about this report

b. Global high-throughput screening market was valued at USD 19.55 Billion in 2019, and is forecast to grow to USD 21.09 Billion by 2020.

b. Global high-throughput screening market will grow at 7.89% compound annual growth rate from 2018 to 2025, to reach USD 30.91 Billion by 2025.

b. With a market share of 58.4%, drug discovery programs dominated high-throughput screening in 2019, This can be attributed to the fact that many of the large and small pharmaceutical companies focus on the manufacturing of novel molecules for multiple life-threatening conditions.

b. b.

b. The market growth is being driven by a rising number of drug targets that can be screened, which are then used for drug discovery and development. There are also growing investments made by governments and research institutes.

Up Market Research published a new report titled “High Throughput Screening (HTS) Market research report which is segmented by Application (Organ-based Screening, Drug Discovery, Cell-, Biochemical Screening), By Players/Companies Inc; PerkinElmer, Inc; Danaher Corporation; Thermofisher Scientific, Agilent Technologies, Inc; Tecan Group Ltd; Merck Millipore; Bio-Rad Laboratories; Hamilton Company; Axxam SpA; and Aurora Biomed”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global High Throughput Screening (HTS) Market Report Segments:

The market is segmented by Application (Organ-based Screening, Drug Discovery, Cell-, Biochemical Screening).

High Throughput Screening (HTS) Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the High Throughput Screening (HTS) Market

Overview of the regional outlook of the High Throughput Screening (HTS) Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The High Throughput Screening (HTS) Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of High Throughput Screening (HTS) Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Organ-based Screening

                2. Drug Discovery

                3. Cell-

                4. Biochemical Screening

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the High Throughput Screening (HTS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the High Throughput Screening (HTS) Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.